GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

XBIO · Dec 31, 2023

Xenetic Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001683168-24-001594General Corporate
Operating cash generation92thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-161.98% · OPTIONAL · VALID

Revenue growth50thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.revenue

48.80% · CORE · VALID

Operating margin92thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.operating_margin

-177.78% · CORE · VALID

R&D intensity17thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

137.59% · OPTIONAL · VALID

SBC intensity8thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

11.15% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History19 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-155.38%
Current
-161.98%
Delta
-6.60%
Growth Increased
Previous
47.54%
Current
48.80%
Delta
1.27%
Profitability Increased
Previous
-187.62%
Current
-177.78%
Delta
9.84%
R And D Intensity Decreased
Previous
166.99%
Current
137.59%
Delta
-29.40%
Sbc Intensity Decreased
Previous
11.50%
Current
11.15%
Delta
-0.35%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.